greeksoup/ stock research
Stock research / United States / HALO / Filings

Halozyme Therapeutics, Inc. SEC filings

In the twelve months since 9 October 2025 Halozyme Therapeutics, Inc. filed 30 documents with the SEC of the kinds listed here: 22 current reports (8-K), about 9 officer or director change; 5 results of operations; 4 other events; 3 material agreement; 3 new financial obligation; 3 quarterly reports (10-Q), 1 annual report to shareholders (ARS), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 annual report (10-K), 1 employee share plan registration (S-8). The latest, filed 30 September 2026: 8-K, officer or director change.

FiledFormWhat it was aboutPeriod or event dateFiling
30 September 20268-KOfficer or director change28 September 2026EDGAR
22 September 20268-KMaterial agreement, New financial obligation, Unregistered sale of equity22 September 2026EDGAR
18 September 20268-KOther events17 September 2026EDGAR
16 September 20268-KOther events16 September 2026EDGAR
18 August 20268-KOfficer or director change14 August 2026EDGAR
6 August 202610-Qquarterly report30 June 2026EDGAR
6 August 20268-KResults of operations6 August 2026EDGAR
2 July 20268-KOfficer or director change30 June 2026EDGAR
11 May 202610-Qquarterly report31 March 2026EDGAR
11 May 20268-KResults of operations11 May 2026EDGAR
7 May 20268-KShareholder vote5 May 2026EDGAR
30 April 20268-KOfficer or director change30 April 2026EDGAR
24 April 20268-KCharter or bylaw amendment, or fiscal year change22 April 2026EDGAR
23 March 2026ARSannual report to shareholders31 December 2025EDGAR
23 March 2026DEFA14Aadditional proxy materialEDGAR
23 March 2026DEF 14Aproxy statement31 December 2025EDGAR
12 March 20268-KOfficer or director change12 March 2026EDGAR
17 February 202610-Kannual report31 December 2025EDGAR
17 February 20268-KResults of operations17 February 2026EDGAR
28 January 20268-KResults of operations28 January 2026EDGAR
9 December 20258-KOfficer or director change4 December 2025EDGAR
8 December 20258-KOfficer or director change4 December 2025EDGAR
24 November 20258-KOfficer or director change18 November 2025EDGAR
18 November 2025S-8employee share plan registrationEDGAR
12 November 20258-KMaterial agreement, New financial obligation, Unregistered sale of equity6 November 2025EDGAR
7 November 20258-KOther events6 November 2025EDGAR
5 November 20258-KMaterial agreement, New financial obligation, Other events5 November 2025EDGAR
3 November 202510-Qquarterly report30 September 2025EDGAR
3 November 20258-KResults of operations, Officer or director change3 November 2025EDGAR
14 October 20258-KRegulation FD disclosure14 October 2025EDGAR
An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.

Source

The company's filing index on EDGAR, read from the SEC's submissions feed.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install